These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 182948)
1. Overdosage with vincristine. Kaufman IA; Kung FH; Koenig HM; Giammona ST J Pediatr; 1976 Oct; 89(4):671-4. PubMed ID: 182948 [TBL] [Abstract][Full Text] [Related]
2. Inappropiate ADH secretion associated with massive vincristine overdosage. Wakem CJ; Bennett JM Aust N Z J Med; 1975 Jun; 5(3):266-9. PubMed ID: 169781 [TBL] [Abstract][Full Text] [Related]
3. Overdose of vincristine: experience with a patient. Chae L; Moon HS; Kim SC J Korean Med Sci; 1998 Jun; 13(3):334-8. PubMed ID: 9681818 [TBL] [Abstract][Full Text] [Related]
6. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia. Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029 [TBL] [Abstract][Full Text] [Related]
7. Toxicity of vincristine overdose in a patient with invasive mole. Takada S; Chen SZ; Mori H Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2617-23. PubMed ID: 2559130 [TBL] [Abstract][Full Text] [Related]
8. Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level). Suskind RM; Brusilow SW; Zehr J J Pediatr; 1972 Jul; 81(1):90-2. PubMed ID: 4338387 [No Abstract] [Full Text] [Related]
9. Neurotoxicity of commonly used antineoplastic agents (second of two parts). Weiss HD; Walker MD; Wiernik PH N Engl J Med; 1974 Jul; 291(3):127-33. PubMed ID: 4365666 [No Abstract] [Full Text] [Related]
10. A massive dose of vincristine. Maeda K; Ueda M; Ohtaka H; Koyama Y; Ohgami M; Miyazaki H Jpn J Clin Oncol; 1987 Sep; 17(3):247-53. PubMed ID: 3669366 [TBL] [Abstract][Full Text] [Related]
12. Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement. Nazir HF; AlFutaisi A; Zacharia M; Elshinawy M; Mevada ST; Alrawas A; Khater D; Jaju D; Wali Y Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28623857 [TBL] [Abstract][Full Text] [Related]
13. Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature. Sathiapalan RK; El-Solh H Pediatr Hematol Oncol; 2001 Dec; 18(8):543-6. PubMed ID: 11764105 [TBL] [Abstract][Full Text] [Related]
14. Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy. Ozyurek H; Turker H; Akbalik M; Bayrak AO; Ince H; Duru F Pediatr Hematol Oncol; 2007 Sep; 24(6):447-52. PubMed ID: 17710662 [TBL] [Abstract][Full Text] [Related]
15. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor. Schiavetti A; Frascarelli M; Uccini S; Novelli A Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281 [TBL] [Abstract][Full Text] [Related]
16. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy. Moudgil SS; Riggs JE Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological Studies to Detect Peripheral Neuropathy in Children Treated With Vincristine. Kavcic M; Koritnik B; Krzan M; Velikonja O; Prelog T; Stefanovic M; Debeljak M; Jazbec J J Pediatr Hematol Oncol; 2017 May; 39(4):266-271. PubMed ID: 28375940 [TBL] [Abstract][Full Text] [Related]